Clinical Risk Grouping Solutions - Global Top Players Market Share and Ranking 2026- YH Research

日本语 | 中文

Home > Reports >Medical Care > Clinical Risk Grouping Solutions - Global Top Players Market Share and Ranking 2026

Clinical Risk Grouping Solutions - Global Top Players Market Share and Ranking 2026

Publication Date: 2026-07-05
Report Id: 3135484
Industry: Medical Care
Report Page: 112
Chart: 119

PDF Download

Publication Date: 2026-07-05
Report Id: 3135484
Industry: Medical Care
Report Page: 112
Chart: 119

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Clinical Risk Grouping Solutions Definition
1.2 Global Clinical Risk Grouping Solutions Market Size and Forecast
1.3 Japan Clinical Risk Grouping Solutions Market Size and Forecast
1.4 Share of Japan Clinical Risk Grouping Solutions Market with Respect to the Global Market
1.5 Clinical Risk Grouping Solutions Market Size: Japan VS Global Growth Rate, 2021-2032
1.6 Clinical Risk Grouping Solutions Market Dynamics
1.6.1 Clinical Risk Grouping Solutions Market Drivers
1.6.2 Clinical Risk Grouping Solutions Market Restraints
1.6.3 Clinical Risk Grouping Solutions Industry Trends
1.6.4 Clinical Risk Grouping Solutions Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of Clinical Risk Grouping Solutions, Global Market Share by Company, 2021-2026
2.2 Global Clinical Risk Grouping Solutions Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Clinical Risk Grouping Solutions Concentration Ratio
2.4 Global Clinical Risk Grouping Solutions Mergers & Acquisitions, Expansion Plans
2.5 Global Clinical Risk Grouping Solutions Major Companies Product Type
2.6 Head Office and Area Served of Key Players

3 Japan Leading Players, Market Share and Ranking
3.1 By Revenue of Clinical Risk Grouping Solutions, Japan Market Share by Company, 2021-2026
3.2 Japan Clinical Risk Grouping Solutions Clinical Risk Grouping Solutions Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 Clinical Risk Grouping Solutions Industry Chain
4.2 Clinical Risk Grouping Solutions Upstream Analysis
4.2.1 Clinical Risk Grouping Solutions Core Raw Materials
4.2.2 Main Manufacturers of Clinical Risk Grouping Solutions Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Clinical Risk Grouping Solutions Production Mode
4.6 Clinical Risk Grouping Solutions Procurement Model
4.7 Clinical Risk Grouping Solutions Industry Sales Model and Sales Channels
4.7.1 Clinical Risk Grouping Solutions Sales Model
4.7.2 Clinical Risk Grouping Solutions Typical Distributors

5 Sights Clinical Risk Grouping Solutions Market Classification
5.1 Clinical Risk Grouping Solutions Classification by Type
5.1.1 Scorecard and Visualization Tools
5.1.2 Dashboard Analysis
5.1.3 Risk Report
5.1.4 by Type, Global Clinical Risk Grouping Solutions Consumption Value & CAGR, 2021 VS 2025 VS 2032
5.1.5 by Type, Global Clinical Risk Grouping Solutions Consumption Value, 2021-2032
5.2 Clinical Risk Grouping Solutions Classification by Technology
5.2.1 Rule-based Risk Models
5.2.2 Statistical Risk Models
5.2.3 Machine Learning Risk Models
5.2.4 AI Deep Learning Risk Models
5.2.5 by Technology, Global Clinical Risk Grouping Solutions Consumption Value & CAGR, 2021 VS 2025 VS 2032
5.2.6 by Technology, Global Clinical Risk Grouping Solutions Consumption Value, 2021-2032
5.3 Clinical Risk Grouping Solutions Classification by Risk Group
5.3.1 Low-Risk Group: Readmission Rate <5%
5.3.2 Medium-Risk Group: Readmission Rate 5%–15%
5.3.3 High-Risk Group: Readmission Rate >15%
5.3.4 by Risk Group, Global Clinical Risk Grouping Solutions Consumption Value & CAGR, 2021 VS 2025 VS 2032
5.3.5 by Risk Group, Global Clinical Risk Grouping Solutions Consumption Value, 2021-2032

6 Sights by Application
6.1 Clinical Risk Grouping Solutions Segment by Application
6.1.1 Hospital
6.1.2 Nursing Center
6.1.3 Other
6.2 by Application, Global Clinical Risk Grouping Solutions Consumption Value & CAGR, 2021 VS 2025 VS 2032
6.3 by Application, Global Clinical Risk Grouping Solutions Consumption Value, 2021-2032

7 Sales Sights by Region
7.1 By Region, Global Clinical Risk Grouping Solutions Consumption Value, 2021 VS 2025 VS 2032
7.2 By Region, Global Clinical Risk Grouping Solutions Consumption Value, 2021-2032
7.3 North America
7.3.1 North America Clinical Risk Grouping Solutions Market Size & Forecasts, 2021-2032
7.3.2 By Country, North America Clinical Risk Grouping Solutions Market Size Market Share
7.4 Europe
7.4.1 Europe Clinical Risk Grouping Solutions Market Size & Forecasts, 2021-2032
7.4.2 By Country, Europe Clinical Risk Grouping Solutions Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Clinical Risk Grouping Solutions Market Size & Forecasts, 2021-2032
7.5.2 By Country/Region, Asia Pacific Clinical Risk Grouping Solutions Market Size Market Share
7.6 South America
7.6.1 South AmericaClinical Risk Grouping Solutions Market Size & Forecasts, 2021-2032
7.6.2 By Country, South America Clinical Risk Grouping Solutions Market Size Market Share
7.7 Middle East & Africa

8 Sales Sights by Country Level
8.1 By Country, Global Clinical Risk Grouping Solutions Market Size & CAGR, 2021 VS 2025 VS 2032
8.2 By Country, Global Clinical Risk Grouping Solutions Consumption Value, 2021-2032
8.3 United States
8.3.1 United States Clinical Risk Grouping Solutions Market Size, 2021-2032
8.3.2 by Type, United States Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032
8.3.3 by Application, United States Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032
8.4 Europe
8.4.1 Europe Clinical Risk Grouping Solutions Market Size, 2021-2032
8.4.2 by Type, Europe Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032
8.4.3 by Application, Europe Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032
8.5 China
8.5.1 China Clinical Risk Grouping Solutions Market Size, 2021-2032
8.5.2 by Type, China Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032
8.5.3 by Application, China Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032
8.6 Japan
8.6.1 Japan Clinical Risk Grouping Solutions Market Size, 2021-2032
8.6.2 by Type, Japan Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032
8.6.3 by Application, Japan Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032
8.7 South Korea
8.7.1 South Korea Clinical Risk Grouping Solutions Market Size, 2021-2032
8.7.2 by Type, South Korea Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032
8.7.3 by Application, South Korea Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032
8.8 Southeast Asia
8.8.1 Southeast Asia Clinical Risk Grouping Solutions Market Size, 2021-2032
8.8.2 by Type, Southeast Asia Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032
8.8.3 by Application, Southeast Asia Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032
8.9 India
8.9.1 India Clinical Risk Grouping Solutions Market Size, 2021-2032
8.9.2 by Type, India Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032
8.9.3 by Application, India Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032
8.10 Middle East & Africa
8.10.1 Middle East & Africa Clinical Risk Grouping Solutions Market Size, 2021-2032
8.10.2 by Type, Middle East & Africa Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032
8.10.3 by Application, Middle East & Africa Clinical Risk Grouping Solutions Consumption Value Market Share, 2025 VS 2032

9 Company Profile
9.1 3M Corporation
9.1.1 3M Corporation Company Information, Head Office, Market Area, and Industry Position
9.1.2 3M Corporation Company Profile and Main Business
9.1.3 3M Corporation Clinical Risk Grouping Solutions Models, Specifications, and Application
9.1.4 3M Corporation Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.1.5 3M Corporation Recent Developments
9.2 Cerner Corporation
9.2.1 Cerner Corporation Company Information, Head Office, Market Area, and Industry Position
9.2.2 Cerner Corporation Company Profile and Main Business
9.2.3 Cerner Corporation Clinical Risk Grouping Solutions Models, Specifications, and Application
9.2.4 Cerner Corporation Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.2.5 Cerner Corporation Recent Developments
9.3 Optum (UnitedHealth Group)
9.3.1 Optum (UnitedHealth Group) Company Information, Head Office, Market Area, and Industry Position
9.3.2 Optum (UnitedHealth Group) Company Profile and Main Business
9.3.3 Optum (UnitedHealth Group) Clinical Risk Grouping Solutions Models, Specifications, and Application
9.3.4 Optum (UnitedHealth Group) Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.3.5 Optum (UnitedHealth Group) Recent Developments
9.4 Epic Systems Corporation
9.4.1 Epic Systems Corporation Company Information, Head Office, Market Area, and Industry Position
9.4.2 Epic Systems Corporation Company Profile and Main Business
9.4.3 Epic Systems Corporation Clinical Risk Grouping Solutions Models, Specifications, and Application
9.4.4 Epic Systems Corporation Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.4.5 Epic Systems Corporation Recent Developments
9.5 Oracle Cerner
9.5.1 Oracle Cerner Company Information, Head Office, Market Area, and Industry Position
9.5.2 Oracle Cerner Company Profile and Main Business
9.5.3 Oracle Cerner Clinical Risk Grouping Solutions Models, Specifications, and Application
9.5.4 Oracle Cerner Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.5.5 Oracle Cerner Recent Developments
9.6 IBM Corporation
9.6.1 IBM Corporation Company Information, Head Office, Market Area, and Industry Position
9.6.2 IBM Corporation Company Profile and Main Business
9.6.3 IBM Corporation Clinical Risk Grouping Solutions Models, Specifications, and Application
9.6.4 IBM Corporation Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.6.5 IBM Corporation Recent Developments
9.7 SAS Institute Inc.
9.7.1 SAS Institute Inc. Company Information, Head Office, Market Area, and Industry Position
9.7.2 SAS Institute Inc. Company Profile and Main Business
9.7.3 SAS Institute Inc. Clinical Risk Grouping Solutions Models, Specifications, and Application
9.7.4 SAS Institute Inc. Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.7.5 SAS Institute Inc. Recent Developments
9.8 Veradigm (Allscripts)
9.8.1 Veradigm (Allscripts) Company Information, Head Office, Market Area, and Industry Position
9.8.2 Veradigm (Allscripts) Company Profile and Main Business
9.8.3 Veradigm (Allscripts) Clinical Risk Grouping Solutions Models, Specifications, and Application
9.8.4 Veradigm (Allscripts) Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.8.5 Veradigm (Allscripts) Recent Developments
9.9 Health Catalyst
9.9.1 Health Catalyst Company Information, Head Office, Market Area, and Industry Position
9.9.2 Health Catalyst Company Profile and Main Business
9.9.3 Health Catalyst Clinical Risk Grouping Solutions Models, Specifications, and Application
9.9.4 Health Catalyst Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.9.5 Health Catalyst Recent Developments
9.10 Cotiviti
9.10.1 Cotiviti Company Information, Head Office, Market Area, and Industry Position
9.10.2 Cotiviti Company Profile and Main Business
9.10.3 Cotiviti Clinical Risk Grouping Solutions Models, Specifications, and Application
9.10.4 Cotiviti Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.10.5 Cotiviti Recent Developments
9.11 IQVIA
9.11.1 IQVIA Company Information, Head Office, Market Area, and Industry Position
9.11.2 IQVIA Company Profile and Main Business
9.11.3 IQVIA Clinical Risk Grouping Solutions Models, Specifications, and Application
9.11.4 IQVIA Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.11.5 IQVIA Recent Developments
9.12 Siemens Healthineers
9.12.1 Siemens Healthineers Company Information, Head Office, Market Area, and Industry Position
9.12.2 Siemens Healthineers Company Profile and Main Business
9.12.3 Siemens Healthineers Clinical Risk Grouping Solutions Models, Specifications, and Application
9.12.4 Siemens Healthineers Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.12.5 Siemens Healthineers Recent Developments
9.13 Philips Healthcare
9.13.1 Philips Healthcare Company Information, Head Office, Market Area, and Industry Position
9.13.2 Philips Healthcare Company Profile and Main Business
9.13.3 Philips Healthcare Clinical Risk Grouping Solutions Models, Specifications, and Application
9.13.4 Philips Healthcare Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.13.5 Philips Healthcare Recent Developments
9.14 Dedalus
9.14.1 Dedalus Company Information, Head Office, Market Area, and Industry Position
9.14.2 Dedalus Company Profile and Main Business
9.14.3 Dedalus Clinical Risk Grouping Solutions Models, Specifications, and Application
9.14.4 Dedalus Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.14.5 Dedalus Recent Developments
9.15 Change Healthcare
9.15.1 Change Healthcare Company Information, Head Office, Market Area, and Industry Position
9.15.2 Change Healthcare Company Profile and Main Business
9.15.3 Change Healthcare Clinical Risk Grouping Solutions Models, Specifications, and Application
9.15.4 Change Healthcare Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.15.5 Change Healthcare Recent Developments
9.16 Yidu Tech
9.16.1 Yidu Tech Company Information, Head Office, Market Area, and Industry Position
9.16.2 Yidu Tech Company Profile and Main Business
9.16.3 Yidu Tech Clinical Risk Grouping Solutions Models, Specifications, and Application
9.16.4 Yidu Tech Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.16.5 Yidu Tech Recent Developments
9.17 Ping An Healthcare
9.17.1 Ping An Healthcare Company Information, Head Office, Market Area, and Industry Position
9.17.2 Ping An Healthcare Company Profile and Main Business
9.17.3 Ping An Healthcare Clinical Risk Grouping Solutions Models, Specifications, and Application
9.17.4 Ping An Healthcare Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.17.5 Ping An Healthcare Recent Developments
9.18 Toshiba
9.18.1 Toshiba Company Information, Head Office, Market Area, and Industry Position
9.18.2 Toshiba Company Profile and Main Business
9.18.3 Toshiba Clinical Risk Grouping Solutions Models, Specifications, and Application
9.18.4 Toshiba Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
9.18.5 Toshiba Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for Clinical Risk Grouping Solutions should grow from US$ 706 million in 2025 to US$ 1115 million by 2032, with a CAGR of 6.7% for the period of 2026-2032.

Clinical Risk Grouping Solutions are analytical systems that utilize artificial intelligence, machine learning, statistical modeling, and clinical rule frameworks to stratify patient populations by health risk, predict disease risks, and optimize the allocation of medical resources. By integrating electronic medical records (EMR), laboratory and imaging data, medication records, genetic information, and health behavior data, these solutions assign risk scores and manage patients within specific categories—such as low, medium, high, and very high-risk groups. Their primary objective is to enable healthcare institutions to implement precision medical management, stratified chronic disease care, inpatient risk prediction, readmission risk control, and cost optimization. Consequently, they enhance care quality, reduce costs, and optimize resource allocation, finding widespread application in hospital administration, insurance payment management, public health, and health management.

Clinical Risk Grouping Solutions

According to YH Research, the global market for Clinical Risk Grouping Solutions should grow from US$ 706 million in 2025 to US$ 1115 million by 2032, with a CAGR of 6.7% for the period of 2026-2032.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

The global landscape for clinical risk grouping solutions is characterized by North American leadership, standardized advancement in Europe, and rapid growth in the Asia-Pacific region. The North American market is primarily driven by insurance payment systems and value-based care models, with applications focused on chronic disease management, readmission risk prediction, cost containment, and population health management. The European market emphasizes regulatory compliance, data privacy protection, and the optimization of public healthcare system efficiency. Meanwhile, the Asia-Pacific region is experiencing surging demand fueled by aging populations, the rising burden of chronic diseases, and the digital transformation of healthcare. The market is currently transitioning from traditional rule-based risk stratification to AI-driven dynamic risk prediction and real-time population health management; clients increasingly prioritize prediction accuracy, clinical interpretability, data integration capabilities, and the optimization of payment efficiency. Future trends include real-time AI risk scoring, clinical risk prediction based on large-scale models, multimodal health data fusion, personalized health intervention recommendations, and integration with health insurance payment models. Key challenges include a lack of unified medical data standards, difficulties in cross-institutional data sharing, insufficient model interpretability, lengthy clinical validation cycles, and strict privacy compliance regulations. The industry's average gross margin typically ranges from 50% to 75%; standardized SaaS-based risk grouping platforms generally command higher margins, whereas customized system integration and clinical implementation projects yield relatively lower margins.

This report studies and analyses global Clinical Risk Grouping Solutions status and future trends, to help determine the Clinical Risk Grouping Solutions market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Clinical Risk Grouping Solutions, and provides market size (US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Clinical Risk Grouping Solutions market size, history data 2021-2025, and forecast data 2026 -2032, (US$ million)
(2) Global Clinical Risk Grouping Solutions by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(3) Japan Clinical Risk Grouping Solutions by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(4) Global Clinical Risk Grouping Solutions key consuming regions, consumption value and demand structure
(5) Clinical Risk Grouping Solutions industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    3M Corporation
    Cerner Corporation
    Optum (UnitedHealth Group)
    Epic Systems Corporation
    Oracle Cerner
    IBM Corporation
    SAS Institute Inc.
    Veradigm (Allscripts)
    Health Catalyst
    Cotiviti
    IQVIA
    Siemens Healthineers
    Philips Healthcare
    Dedalus
    Change Healthcare
    Yidu Tech
    Ping An Healthcare
    Toshiba

Market segment by Type, covers
    Scorecard and Visualization Tools
    Dashboard Analysis
    Risk Report

Market segment by Technology, covers
    Rule-based Risk Models
    Statistical Risk Models
    Machine Learning Risk Models
    AI Deep Learning Risk Models

Market segment by Risk Group, covers
    Low-Risk Group: Readmission Rate <5%
    Medium-Risk Group: Readmission Rate 5%–15%
    High-Risk Group: Readmission Rate >15%

Market segment by Application, can be divided into
    Hospital
    Nursing Center
    Other

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Clinical Risk Grouping Solutions product scope, global consumption value, Japan consumption value, development opportunities, challenges, trends, and policies
Chapter 2: Global Clinical Risk Grouping Solutions market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 3: Japan Clinical Risk Grouping Solutions market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 4: Clinical Risk Grouping Solutions industry chain, upstream, medium-stream, and downstream
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2021-2032
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2021-2032
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin
Chapter 10: Conclusions